Results 181 to 190 of about 51,825 (261)

Emerging Pharmacological and Invasive Therapies for Hypertrophic Cardiomyopathy with Obstructive Physiology. [PDF]

Card Fail Rev
Li-Wen Chu E, Seung Kim D, Masri A.
europepmc   +1 more source

805 Clonal, activated CD8+ T cells recognizing cardiac alpha-myosin drive immune checkpoint inhibitor associated myocarditis in mice

Journal for ImmunoTherapy of Cancer, 2021
James Allison, Spencer Wei, Douglas Johnson, Elizabeth Wescott, Justin Balko, Margaret Axelrod, Wouter Meijers, Elie Tannous, Xiaopeng Sun, Juan Qin, Ayaka Sugiura, Elles Screever, Susan Opalenik, Yueli Zhang, Javid Moslehi   +14 more
doaj   +1 more source

ODYSSEY-HCM trial (mavacamten in symptomatic nonobstructive hypertrophic cardiomyopathy). [PDF]

Eur Heart J Cardiovasc Pharmacother
Monda E, Limongelli G.
europepmc   +1 more source

Catastrophic apical ballooning in an obstructive hypertrophic cardiomyopathy patient treated with mavacamten: case report. [PDF]

Eur Heart J Case Rep
De Roeck F, Lahaye F, Gevaert AB, De Paep R, Van Craenenbroeck E.   +4 more
europepmc   +1 more source

A myosin hypertrophic cardiomyopathy mutation disrupts the super-relaxed state and boosts contractility by enhanced actin attachment. [PDF]

Proc Natl Acad Sci U S A
Cail RC, Barua B, Báez-Cruz FA, Winkelmann DA, Goldman YE, Ostap EM.   +5 more
europepmc   +1 more source

Improved synthesis and comparative analysis of the tool properties of new and existing D-ring modified (S)-blebbistatin analogs [PDF]

, 2017
Bracke, Marc, Roman, Bart, Stevens, Christian, Verhasselt, Sigrid   +3 more
core   +2 more sources

Coexistence of Hypertrophic Cardiomyopathy and Arterial Hypertension: Current Insights and Future Directions. [PDF]

Diseases
Katsi V, Papadomarkaki K, Manousiadis K, Triantafyllou E, Fragoulis C, Tsioufis K.   +5 more
europepmc   +1 more source

Comprehensive improvement in cardiac function following myosin inhibition after the ineffectiveness of myectomy and alcohol septal ablation: a case report. [PDF]

Eur Heart J Case Rep
Aleksandrov A, Haverkamp W, Borges AC, Zöller T, Knebel F.   +4 more
europepmc   +1 more source

Complete left bundle branch block resolution during treatment with Mavacamten: a case report of a first-in-class scenario. [PDF]

Eur Heart J Case Rep
Marchionni G, Alfarano M, Ballatore F, Costantino J, Chimenti C.   +4 more
europepmc   +1 more source

Cardiomyocyte maturation and proliferation is a flip coin. [PDF]

BMC Cardiovasc Disord
Abouleisa RRE, Farraj KA, Mehta SG, Mohamed TMA.   +3 more
europepmc   +1 more source